Changing physician prescribing behavior: the community-acquired pneumonia intervention trial.
The Notes section welcomes the following types of contributions: (1) practical innovations or solutions to everyday practice problems, (2) substantial updates or elaborations on work previously published by the same authors, (3) important confirmations of research findings previously published by others, and (4) short research reports, including practice surveys, of modest scope or interest. Notes should be submitted with AJHP's manuscript checklist. The text should be concise, and the number of references, tables, and figures should be limited.
Coley
K C
KC
School of Pharmacy, University of Pittsburgh, PA 15261, USA. coley@pitt.edu
Skledar
S J
SJ
Fine
M J
MJ
Yealy
D M
DM
Gleason
P P
PP
Ryan
M L
ML
Kapoor
W
W
Branch
R A
RA
D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D016022:Case-Control Studies; D002444:Cefuroxime / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000145:classification / Q000188:drug therapy; D011307:Drug Prescriptions; D004636:Emergency Service, Hospital; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D010819:Physician's Role; D011014:Pneumonia / Q000145:classification / Q000188:drug therapy*; D012720:Severity of Illness Index
D000890:Anti-Infective Agents; D002511:Cephalosporins; D002444:Cefuroxime